hi all, i'm curious if anyone knows when novartis' patent/exclusivity rights on imatinib expire? in other words, when will generic gleevec be on the market in the US? i know there is a generic version currently manufactured in india by sunpharma, but obviously, this is not available here due to patent law. i also know that imatinib is consider an orphan class drug due to the small size of its target population, which gives novartis a longer period of exclusivity than normal. any ideas? i have access to the drug, that is not a problem, i'm just curious when the extortionary profits novartis is currently enjoying will decrease to a reasonable level. best, daniel --~--~---------~--~----~------------~-------~--~----~ [CMLHope] A support group of http://cmlhope.com -------------------------------------------------
You received this message because you are subscribed to the Google Groups "CMLHope" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [EMAIL PROTECTED] For more options, visit this group at http://groups.google.com/group/CMLHope -~----------~----~----~----~------~----~------~--~---
